Published in Hum Reprod Update on December 18, 2008
INTEnsity of ovariaN Stimulation and Embryo Quality (INTENS-EQ) | NCT04983173
A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos. Biomed Res Int (2017) 1.40
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients. Reprod Biol Endocrinol (2011) 1.09
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization. Reprod Biol Endocrinol (2011) 1.08
Approaches to improve the diagnosis and management of infertility. Hum Reprod Update (2009) 1.04
Gonadotropin therapy: a 20th century relic. Fertil Steril (2012) 1.03
Association of number of retrieved oocytes with live birth rate and birth weight: an analysis of 231,815 cycles of in vitro fertilization. Fertil Steril (2015) 0.90
Promotion of human early embryonic development and blastocyst outgrowth in vitro using autocrine/paracrine growth factors. PLoS One (2012) 0.87
Serum human chorionic gonadotropin levels on the day before oocyte retrieval do not correlate with oocyte maturity. Fertil Steril (2013) 0.81
MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study including thawing cycles. J Assist Reprod Genet (2012) 0.80
Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue? J Ovarian Res (2015) 0.80
Embryo wastage rates remain high in assisted reproductive technology (ART): a look at the trends from 2004-2013 in the USA. J Assist Reprod Genet (2016) 0.79
Why more is less and less is more when it comes to ovarian stimulation. J Assist Reprod Genet (2015) 0.79
Should mild stimulation be the order of the day? J Hum Reprod Sci (2013) 0.78
Mild ovarian stimulation for in vitro fertilization: one perspective from the USA. J Assist Reprod Genet (2013) 0.78
Comparison of GnRH agonist, GnRH antagonist, and GnRH antagonist mild protocol of controlled ovarian hyperstimulation in good prognosis patients. Int J Endocrinol (2015) 0.77
Effect of lower than expected number of oocyte on the IVF results after oocyte-pickup. Int J Clin Exp Med (2014) 0.77
Anti Mullerian Hormone: Ovarian response indicator in young patients receiving Long GnRH Agonist Protocol for Ovarian Stimulation. Pak J Med Sci (2016) 0.75
Contributing factors for the incidence of aneuploidy in older patients undergoing intracytoplasmic sperm injection cycles. J Assist Reprod Genet (2012) 0.75
Use of clomiphene-based stimulation protocol in oocyte donors: A comparative study. J Hum Reprod Sci (2016) 0.75
Accumulation of oocytes from a few modified natural cycles to improve IVF results: a pilot study. J Assist Reprod Genet (2013) 0.75
The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer. Reprod Biol Endocrinol (2015) 0.75
A comparison of the use of clomiphene citrate and letrozole in patients undergoing IVF with the objective of producing only one or two embryos. Facts Views Vis Obgyn (2015) 0.75
Oocyte cryopreservation beyond cancer: tools for ethical reflection. J Assist Reprod Genet (2015) 0.75
The luteinizing hormone beta-subunit exon 3 (Gly102Ser) gene mutation and ovarian responses to controlled ovarian hyperstimulation. Iran J Reprod Med (2014) 0.75
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod (2011) 5.49
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod (2002) 3.59
Fertility and ageing. Hum Reprod Update (2005) 2.68
Why do couples drop-out from IVF treatment? A prospective cohort study. Hum Reprod (2008) 2.32
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update (2006) 2.26
Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Hum Reprod Update (2002) 2.08
Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod (2009) 2.03
Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab (2011) 2.02
Economic evaluation of the administration of follitropin-beta with a pen device. Reprod Biomed Online (2005) 1.99
Mouse MutS-like protein Msh5 is required for proper chromosome synapsis in male and female meiosis. Genes Dev (1999) 1.95
Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples. Hum Reprod (2006) 1.86
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod (2011) 1.80
PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG (2006) 1.77
A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update (2005) 1.63
A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod (2009) 1.58
Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF. Hum Reprod (2005) 1.58
Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online (2006) 1.53
Breastfeeding modulates neonatal innate immune responses: a prospective birth cohort study. Pediatr Allergy Immunol (2011) 1.49
Mild ovarian stimulation for IVF. Hum Reprod Update (2008) 1.48
Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.48
Mammography: interobserver variability in breast density assessment. Breast (2007) 1.44
Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. J Assist Reprod Genet (2005) 1.42
[The guideline 'Recurrent miscarriage' (first revision) of the Dutch Society for Obstetrics and Gynaecology]. Ned Tijdschr Geneeskd (2008) 1.41
Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod (2009) 1.40
[Pregnancy at a later age with the help of oocyte donation]. Ned Tijdschr Geneeskd (2006) 1.38
Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab (2012) 1.35
Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod (2007) 1.32
Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril (1999) 1.32
The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update (2011) 1.32
Associations between dietary patterns and semen quality in men undergoing IVF/ICSI treatment. Hum Reprod (2009) 1.30
Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update (2008) 1.30
Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod (2004) 1.29
Health-related quality of life in relation to gender and age in couples planning IVF treatment. Hum Reprod (2003) 1.28
The role of the endometrium and embryo in human implantation. Hum Reprod Update (2007) 1.24
The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod (2003) 1.23
Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online (2008) 1.21
Estimation of the frequency of involuntary infertility on a nation-wide basis. Hum Reprod (2012) 1.18
A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril (2000) 1.18
Low negative affect prior to treatment is associated with a decreased chance of live birth from a first IVF cycle. Hum Reprod (2007) 1.17
Molecular aspects of implantation failure. Biochim Biophys Acta (2012) 1.17
Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod (2009) 1.15
The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod (2007) 1.15
Age at menopause as a marker of reproductive ageing. Maturitas (1998) 1.12
Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol (1998) 1.10
Testing ovarian reserve to predict age at menopause. Maturitas (2009) 1.08
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. BJOG (2009) 1.08
The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy. Hum Reprod (2007) 1.08
Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. J Clin Endocrinol Metab (2013) 1.07
Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Hum Reprod Update (2008) 1.07
Approaches to improve the diagnosis and management of infertility. Hum Reprod Update (2009) 1.04
What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment. Hum Reprod (2004) 1.01
A prospective randomized comparison of sequential versus monoculture systems for in-vitro human blastocyst development. Hum Reprod (2002) 1.01
Current value of preimplantation genetic aneuploidy screening in IVF. Hum Reprod Update (2006) 1.01
Intracytoplasmic sperm injection (ICSI) and chromosomally abnormal spermatozoa. Hum Reprod (1997) 1.01
Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis. Br J Cancer (2007) 1.00
Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation. Heart (2004) 1.00
Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod (2009) 1.00
Fluorescence in situ hybridization analysis of two blastomeres from day 3 frozen-thawed embryos followed by analysis of the remaining embryo on day 5. Hum Reprod (2004) 0.98
Implantation of the human embryo: research lines and models. From the implantation research network 'Fruitful'. Gynecol Obstet Invest (2006) 0.98
Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint. Hum Reprod (2007) 0.98
Parental origin of chromatin in human monopronuclear zygotes revealed by asymmetric histone methylation patterns, differs between IVF and ICSI. Mol Reprod Dev (2009) 0.98
Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea. Hum Reprod (2012) 0.97
Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril (2000) 0.97
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod (2008) 0.96